EIF4G1 and cancer: In addition to disrupting the interaction with eIF4G in three different human cancer cell lysates, an in vitro translation assay from HeLa cells revealed that compound 4 significantly inhibited cap-dependent translation (Fig. 4h between 1 and 10 μM (EC50 ≈ 4 μM).